Alnylam Pharmaceuticals, Inc.

NISSAY ASSET MANAGEMENT CORP /JAPAN ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

35,813

Value ($000)

14,241

Weight

0.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	14,241	0.1%	35,813	12/31/2025
2025 Q3	11/14/2025	7,558	0.0%	16,575	9/30/2025
2025 Q2	8/14/2025	5,311	0.0%	16,288	6/30/2025
2025 Q1	5/15/2025	4,378	0.0%	16,214	3/31/2025
2024 Q4	2/14/2025	3,795	0.0%	15,947	12/31/2024
2024 Q3	11/14/2024	4,297	0.0%	15,623	9/30/2024
2024 Q2	8/14/2024	3,913	0.0%	16,101	6/30/2024
2024 Q1	5/15/2024	2,328	0.0%	15,577	3/31/2024
2023 Q4	2/14/2024	2,921	0.0%	15,258	12/31/2023
2023 Q3	11/14/2023	2,616	0.0%	14,773	9/30/2023
2023 Q2	8/14/2023	2,704	0.0%	14,236	6/30/2023
2023 Q1	5/15/2023	2,908	0.0%	14,516	3/31/2023
2022 Q4	2/14/2023	3,496	0.0%	14,710	12/31/2022
2022 Q3	11/14/2022	2,954	0.0%	14,758	9/30/2022
2022 Q2	8/15/2022	2,071	0.0%	14,202	6/30/2022
2022 Q1	5/16/2022	2,290	0.0%	14,023	3/31/2022
2021 Q4	2/14/2022	2,313	0.0%	13,637	12/31/2021
2021 Q3	11/10/2021	2,505	0.0%	13,266	9/30/2021
2021 Q2	8/13/2021	1,925	0.0%	11,353	6/30/2021
2021 Q1	5/11/2021	1,565	0.0%	11,083	3/31/2021
2020 Q4	2/8/2021	1,478	0.0%	11,372	12/31/2020
2020 Q3	10/20/2020	1,680	0.0%	11,540	9/30/2020
2020 Q2	7/27/2020	1,639	0.0%	11,066	6/30/2020
2020 Q1	5/5/2020	1,046	0.0%	9,611	3/31/2020
2019 Q4	2/14/2020	1,061	0.0%	9,211	12/31/2019